|
Sep 28
|
Eli Lilly settles whistleblower lawsuit over manufacturing problems
|
|
Sep 28
|
Nektar (NKTR), Cellular Biomedicine Join for Lung Cancer Studies
|
|
Sep 28
|
INSIGHT-Wegovy, other weight-loss drugs scrutinized over reports of suicidal thoughts
|
|
Sep 27
|
Amazon Health: A long play and a search for partners
|
|
Sep 27
|
Amgen Could Get a Piece of the Obesity Market
|
|
Sep 26
|
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
|
|
Sep 26
|
The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out
|
|
Sep 26
|
2 Magnificent Dividend Stocks to Buy Right Now
|
|
Sep 26
|
Wall Street Expects Historic Sales from Ozempic and Other Obesity Treatments
|
|
Sep 26
|
Top 20 Breakthrough Pharmaceutical Drugs of the Decade
|
|
Sep 25
|
FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease
|
|
Sep 25
|
10 Best Ways to Prevent Type 2 Diabetes
|
|
Sep 25
|
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
|
|
Sep 24
|
3 Magnificent Growth Stocks to Buy Right Now
|
|
Aug 11
|
Pharma ETFs in Focus Post Q2 Earnings
|
|
Aug 11
|
Why Shares of Eli Lilly Jumped This Week
|
|
Aug 11
|
Lilly Endowment Inc. Reduces Stake in Eli Lilly and Co.
|
|
Aug 11
|
Market Rally On The Ropes, AI Stocks Tumble: Weekly Review
|
|
Aug 11
|
Pharma Stock Roundup: LLY, BAYRY Post Q2 Results, NVO's Wegovy Cuts Heart Attack Risk
|
|
Aug 10
|
UPDATE 1-Obesity drug data could boost companies' case for US coverage-analysts
|